Effect of Androgen Deprivation Therapy on the Results of PET/CT with 18F-Fluciclovine in Patients with Metastatic Prostate Cancer

Background: 18F-fluciclovine is a positron emission tomography (PET) radiotracer approved for the detection of prostate cancer recurrence. No effect of androgen deprivation therapy (ADT) on its performance has been established. Purpose: To study the impact of concurrent ADT on disease detection with...

Descripción completa

Detalles Bibliográficos
Autores principales: Bach-Gansmo, Tore, Korsan, Katrine, Bogsrud, Trond Velde
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230844/
https://www.ncbi.nlm.nih.gov/pubmed/35736868
http://dx.doi.org/10.3390/tomography8030120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230844/
https://www.ncbi.nlm.nih.gov/pubmed/35736868
http://dx.doi.org/10.3390/tomography8030120

Ejemplares similares